beijing tong ren tang chinese medic - BJTRF

BJTRF

Close Chg Chg %
1.50 -0.85 -56.77%

Closed Market

0.65

-0.85 (56.77%)

Volume: 800.00

Last Updated:

Apr 1, 2024, 9:30 AM EDT

Company Overview: beijing tong ren tang chinese medic - BJTRF

BJTRF Key Data

Open

$0.65

Day Range

0.65 - 0.65

52 Week Range

0.65 - 1.50

Market Cap

$904.07M

Shares Outstanding

837.10M

Public Float

236.30M

Beta

0.30

Rev. Per Employee

N/A

P/E Ratio

14.32

EPS

$0.08

Yield

390.36%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

BJTRF Performance

No Data Available

BJTRF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About beijing tong ren tang chinese medic - BJTRF

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. It operates through the following geographical segments: Hong Kong, Mainland China and Overseas. The Hong Kong segment sells Chinese medicine and healthcare products and provides medical consultation and treatments through retail outlets, as well as wholesale in Hong Kong. The Mainland China segment engages in the wholesale of healthcare products in the Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside the Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments in other overseas countries/regions, including Macao. The company was founded in 1669 and is headquartered in Hong Kong.

BJTRF At a Glance

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Room 1405-1409, Office Tower
Hong Kong,
Phone 852-3657-5819 Revenue 194.78M
Industry Pharmaceuticals: Major Net Income 69.03M
Sector Health Technology Employees 798
Fiscal Year-end 12 / 2024
View SEC Filings

BJTRF Valuation

P/E Current 14.32
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 18.845
Price to Sales Ratio 6.682
Price to Book Ratio 2.628
Price to Cash Flow Ratio 19.444
Enterprise Value to EBITDA 11.58
Enterprise Value to Sales 5.306
Total Debt to Enterprise Value 0.016

BJTRF Efficiency

Revenue/Employee 244,088.99
Income Per Employee 86,497.534
Receivables Turnover 3.596
Total Asset Turnover 0.349

BJTRF Liquidity

Current Ratio 11.652
Quick Ratio 8.586
Cash Ratio 7.21

BJTRF Profitability

Gross Margin 64.016
Operating Margin 40.404
Pretax Margin 45.316
Net Margin 35.437
Return on Assets 12.38
Return on Equity 14.426
Return on Total Capital 13.48
Return on Invested Capital 14.167

BJTRF Capital Structure

Total Debt to Total Equity 3.409
Total Debt to Total Capital 3.297
Total Debt to Total Assets 2.956
Long-Term Debt to Equity 1.95
Long-Term Debt to Total Capital 1.886
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Beijing Tong Ren Tang Chinese Medic - BJTRF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
169.59M 200.20M 221.07M 194.78M
Sales Growth
-7.25% +18.05% +10.42% -11.89%
Cost of Goods Sold (COGS) incl D&A
48.30M 57.21M 82.39M 70.09M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
10.07M 9.00M 9.64M 10.54M
Depreciation
9.32M 8.71M 9.23M 10.11M
Amortization of Intangibles
749.61K 290.11K 404.57K 429.56K
COGS Growth
-12.38% +18.45% +44.01% -14.92%
Gross Income
121.29M 143.00M 138.69M 124.69M
Gross Income Growth
-5.04% +17.89% -3.01% -10.09%
Gross Profit Margin
+71.52% +71.43% +62.73% +64.02%
2020 2021 2022 2023 5-year trend
SG&A Expense
38.25M 43.87M 36.27M 45.99M
Research & Development
1.22M 1.45M 983.21K 1.56M
Other SG&A
37.03M 42.42M 35.29M 44.43M
SGA Growth
-14.88% +14.67% -17.31% +26.79%
Other Operating Expense
- - - 27.08K
-
Unusual Expense
- (433.21K) (62.14K) (11.49K)
EBIT after Unusual Expense
83.44M 99.19M 102.42M 78.70M
Non Operating Income/Expense
5.65M 1.52M 3.85M 10.33M
Non-Operating Interest Income
2.79M 563.11K 2.63M 9.31M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
554.41K 605.57K 595.24K 763.58K
Interest Expense Growth
+3.25% +9.23% -1.71% +28.28%
Gross Interest Expense
554.41K 605.57K 595.24K 763.58K
Interest Capitalized
- - - -
-
Pretax Income
88.55M 100.11M 105.68M 88.27M
Pretax Income Growth
+0.37% +13.06% +5.56% -16.47%
Pretax Margin
+52.21% +50.00% +47.80% +45.32%
Income Tax
15.22M 16.32M 17.20M 12.42M
Income Tax - Current - Domestic
15.69M 17.29M 16.33M 15.12M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(473.18K) (972.36K) 863.93K (2.70M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
73.22M 83.82M 88.28M 75.44M
Minority Interest Expense
3.28M 5.62M 5.80M 6.41M
Net Income
69.94M 78.20M 82.48M 69.03M
Net Income Growth
-1.46% +11.81% +5.48% -16.32%
Net Margin Growth
+41.24% +39.06% +37.31% +35.44%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
69.94M 78.20M 82.48M 69.03M
Preferred Dividends
- - - -
-
Net Income Available to Common
69.94M 78.20M 82.48M 69.03M
EPS (Basic)
0.0836 0.0934 0.0985 0.0825
EPS (Basic) Growth
-1.42% +11.72% +5.46% -16.24%
Basic Shares Outstanding
837.10M 837.10M 837.10M 837.10M
EPS (Diluted)
0.0836 0.0934 0.0985 0.0825
EPS (Diluted) Growth
-1.42% +11.72% +5.46% -16.24%
Diluted Shares Outstanding
837.10M 837.10M 837.10M 837.10M
EBITDA
93.08M 108.13M 112.05M 89.24M
EBITDA Growth
+0.19% +16.17% +3.62% -20.36%
EBITDA Margin
+54.88% +54.01% +50.69% +45.82%

Beijing Tong Ren Tang Chinese Medic in the News